Sanai Health Industry Group Company Limited (1889.HK)
HKSE · HKD · Healthcare · Drug Manufacturers - Specialty & Generic
HK$0.15 (-6.25%) as of
Key statistics
- Market cap
- 22.93M
- EPS (TTM)
- -0.130
- Dividend yield
- 0.00%
- 52-week range
- 0.127 – 0.650
- Beta
- -1.08
- Revenue (TTM)
- 82.6M
- Profit margin
- -23.59%
- Volume
- 44.00k
About Sanai Health Industry Group Company Limited
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Kwun Tong, Hong Kong
- Employees
- 140
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.